What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?
Enrico De Lorenzis, G. Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese
Topics & Concepts
DermatomyositisCoronavirus disease 2019 (COVID-19)Interstitial lung diseaseMDA5Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LungDiseaseVirologyDermatologyPathologyOutbreakInfectious disease (medical specialty)Internal medicineBiologyRNA interferenceRNAGeneBiochemistryInflammatory Myopathies and DermatomyositisInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisImmunodeficiency and Autoimmune Disorders